Location: Menlo Park, CA
CIK: 0001540358 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.58B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FIG | FIGMA INC | 16,246,129 | $607M | 38.4% | $68.66 | -34.2% | CLASS A COM STK | 316841105 |
| NAVN | NAVAN INC | 27,195,364 | $464M | 29.4% | $15.89 | 0.0% | CL A | 639193101 |
| META | META PLATFORMS INC | 212,531 | $140M | 8.9% | $743.23 | -10.2% | CL A | 30303M102 |
| RVMD | REVOLUTION MEDICINES INC | 921,099 | $73.37M | 4.6% | $24.03 | +172.9% | COM | 76155X100 |
| MAZE | MAZE THERAPEUTICS INC | 1,702,225 | $70.52M | 4.5% | $12.04 | +185.5% | COM | 578784100 |
| XYZ | BLOCK INC | 1,016,697 | $66.18M | 4.2% | $56.54 | +22.0% | CL A | 852234103 |
| OMDA | OMADA HEALTH INC | 3,460,929 | $54.61M | 3.5% | $17.31 | +17.2% | COM | 68170A108 |
| BIOA | BIOAGE LABS INC | 3,233,170 | $44.07M | 2.8% | $19.85 | -55.3% | COM | 09077V100 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 17,653,917 | $34.43M | 2.2% | $2.86 | -42.7% | COM | 63909J108 |
| CAMP | CAMP4 THERAPEUTICS CORP | 2,125,339 | $13.03M | 0.8% | $8.22 | -48.2% | COM | 13463J101 |
| ERAS | ERASCA INC | 2,862,500 | $10.65M | 0.7% | $2.11 | +33.4% | COM | 29479A108 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 108,568 | $902K | 0.1% | $10.02 | +7.4% | CL A NEW | 37611X209 |
| HTBK | HERITAGE COMM CORP | 82,740 | $129K | 0.0% | $10.85 | 0.0% | COM | 426927109 |